Sources Describe Pelosi’s Closely Held Drug-Price Negotiation Plan

By Rachel Cohrs / May 8, 2019 at 5:49 PM

House Speaker Nancy Pelosi’s (D-CA) office is working on a drug-price negotiation bill that would use arbitration as a backstop to price negotiations between HHS and drug makers on high-cost drugs, and the resulting price could be available to other payers, not just to Medicare plans, sources briefed on the plan told Inside Drug Pricing.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.